Related Articles
PUMA decreases the growth of prostate cancer PC-3 cells independent of p53
Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro
MHY-449, a novel dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces apoptotic cell death through modulation of Akt/FoxO1 and ERK signaling in PC3 human prostate cancer cells
Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle
Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells